Starling Oncology (STLN) EBIT Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | -84.98% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 82.38% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | -26.05% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 7.65% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 3.28% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 17.90% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 31.02% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 35.82% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 28.51% |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | 58.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.83% |
| Mar 31, 2026 | 34.29% |
| Dec 31, 2025 | 42.10% |
| Sep 30, 2025 | 41.86% |
| Jun 30, 2025 | 31.49% |
| Mar 31, 2025 | 44.85% |
| Dec 31, 2024 | 21.97% |
| Sep 30, 2024 | 0.52% |
| Jun 30, 2024 | -9.55% |
| Mar 31, 2024 | 45.32% |
| Dec 31, 2023 | 39.04% |
| Sep 30, 2023 | 30.71% |
| Jun 30, 2023 | 18.39% |
| Mar 31, 2023 | -77.94% |
| Dec 31, 2022 | 38.58% |
| Sep 30, 2022 | -831.71% |
| Jun 30, 2022 | -1,540.14% |
| Mar 31, 2022 | -953.68% |
| Dec 31, 2021 | -429.17% |
| Sep 30, 2021 | -986.76% |